Krenciute G - Search Results

1

Antitumor Effects of CAR T Cells Redirected to the EDB Splice Variant of Fibronectin.

Wagner J, Wickman E, Shaw TI, Anido AA, Langfitt D, Zhang J, Porter SN, Pruett-Miller SM, Tillman H, Krenciute G, Gottschalk S. Wagner J, et al. Among authors: krenciute g. Cancer Immunol Res. 2020 Dec 22. doi: 10.1158/2326-6066.CIR-20-0280. Online ahead of print. Cancer Immunol Res. 2020. PMID: 33355188

2

Cell surface antigen profiling of pediatric brain tumors: B7-H3 is consistently expressed and can be targeted via local or systemic CAR T-cell delivery.

Haydar D, Houke H, Chiang J, Yi Z, Odé Z, Caldwell K, Zhu X, Mercer KS, Stripay JL, Shaw TI, Vogel P, DeRenzo C, Baker SJ, Roussel MF, Gottschalk S, Krenciute G. Haydar D, et al. Among authors: krenciute g. Neuro Oncol. 2020 Dec 15:noaa278. doi: 10.1093/neuonc/noaa278. Online ahead of print. Neuro Oncol. 2020. PMID: 33320196

3

Chimeric antigen receptor T-cell therapy in glioblastoma: charging the T cells to fight.

Land CA, Musich PR, Haydar D, Krenciute G, Xie Q. Land CA, et al. Among authors: krenciute g. J Transl Med. 2020 Nov 11;18(1):428. doi: 10.1186/s12967-020-02598-0. J Transl Med. 2020. PMID: 33176788 Free PMC article. Review.

4

MyD88/CD40 signaling retains CAR T cells in a less differentiated state.

Prinzing B, Schreiner P, Bell M, Fan Y, Krenciute G, Gottschalk S. Prinzing B, et al. Among authors: krenciute g. JCI Insight. 2020 Nov 5;5(21):e136093. doi: 10.1172/jci.insight.136093. JCI Insight. 2020. PMID: 33148882 Free PMC article.

5

What is the Optimal Design-Build-Test Cycle for Clinically Relevant Synthetic CAR T Cell Therapies?

Chen YY, Lim W, Levings M, Blazar B, Krenciute G, Wong W, Lehner M. Chen YY, et al. Among authors: krenciute g. Cell Syst. 2020 Sep 23;11(3):212-214. doi: 10.1016/j.cels.2020.08.017. Cell Syst. 2020. PMID: 32970992 Free PMC article. No abstract available.

6

Route of 41BB/41BBL Costimulation Determines Effector Function of B7-H3-CAR.CD28ζ T Cells.

Nguyen P, Okeke E, Clay M, Haydar D, Justice J, O'Reilly C, Pruett-Miller S, Papizan J, Moore J, Zhou S, Throm R, Krenciute G, Gottschalk S, DeRenzo C. Nguyen P, et al. Among authors: krenciute g. Mol Ther Oncolytics. 2020 Jun 23;18:202-214. doi: 10.1016/j.omto.2020.06.018. eCollection 2020 Sep 25. Mol Ther Oncolytics. 2020. PMID: 32728609 Free PMC article.

7

CRISPR-Mediated Non-Viral Site-Specific Gene Integration and Expression in T Cells: Protocol and Application for T-Cell Therapy.

Odé Z, Condori J, Peterson N, Zhou S, Krenciute G. Odé Z, et al. Among authors: krenciute g. Cancers (Basel). 2020 Jun 26;12(6):1704. doi: 10.3390/cancers12061704. Cancers (Basel). 2020. PMID: 32604839 Free PMC article.

8

CHANGE-seq reveals genetic and epigenetic effects on CRISPR-Cas9 genome-wide activity.

Lazzarotto CR, Malinin NL, Li Y, Zhang R, Yang Y, Lee G, Cowley E, He Y, Lan X, Jividen K, Katta V, Kolmakova NG, Petersen CT, Qi Q, Strelcov E, Maragh S, Krenciute G, Ma J, Cheng Y, Tsai SQ. Lazzarotto CR, et al. Among authors: krenciute g. Nat Biotechnol. 2020 Nov;38(11):1317-1327. doi: 10.1038/s41587-020-0555-7. Epub 2020 Jun 15. Nat Biotechnol. 2020. PMID: 32541958 Free PMC article.

9

Next Generation CAR T Cells for the Immunotherapy of High-Grade Glioma.

Petersen CT, Krenciute G. Petersen CT, et al. Among authors: krenciute g. Front Oncol. 2019 Feb 26;9:69. doi: 10.3389/fonc.2019.00069. eCollection 2019. Front Oncol. 2019. PMID: 30863720 Free PMC article. Review.

10

The Landscape of CAR T Cells Beyond Acute Lymphoblastic Leukemia for Pediatric Solid Tumors.

DeRenzo C, Krenciute G, Gottschalk S. DeRenzo C, et al. Among authors: krenciute g. Am Soc Clin Oncol Educ Book. 2018 May 23;38:830-837. doi: 10.1200/EDBK_200773. Am Soc Clin Oncol Educ Book. 2018. PMID: 30231350 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results